| 88999-8 |
Eicosapentaenoate+docosahexaenoate/Fatty acids.C14-C24 index risk |
Imp |
Ser/Plas |
Pt |
Ord |
|
|
ACTIVE |
Omega-3 (EPA+DHA) index risk in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
88999-8 |
|
|
|
|
Both |
|
|
|
0 |
Omega-3 index risk SFr SerPl |
|
|
|
|
|
Acd; Acid; C20:5w3; C22:6w3; Cervonate; Cervonic acid; Chemistry; DHA; Docosahexaenoic acid; Eicosapentaenoic acid; EPA; EPA+DHA; Fatty acid; Icosapentaenoate; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Lipid; Ordinal; Pl; Plasma; Plsm; Point in time; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Timnodonate; Timnodonic Acid |
2.73 |
2.64 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 89-3 |
Cefmetazole |
Susc |
Isolate |
Pt |
OrdQn |
Agar diffusion |
|
ACTIVE |
Cefmetazole [Susceptibility] by Disk diffusion (KB) |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
89-3 |
|
Agar diffusion |
|
|
Observation |
|
|
|
0 |
Cefmetazole Islt KB |
|
|
|
|
|
ANTIBIOTIC SUSCEPTIBILITIES; AST; Cefmetazon; Cemetol; Disk diffusion; ID; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Kirby-bauer; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Zefazone |
2.19 |
1 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 890-4 |
Blood group antibody |
PrThr |
Ser/Plas |
Pt |
Ord |
Blood group antibody screen |
|
ACTIVE |
Blood group antibody screen [Presence] in Serum or Plasma |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
BLDBK |
|
890-4 |
|
Blood group antibody screen |
|
|
Both |
|
|
|
0 |
Bld gp Ab Scn SerPl Ql |
|
|
|
|
|
Ab; Bld gp Ab Scn; BLOOD BANK; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders |
2.79 |
1 |
|
|
|
|
|
|
|
|
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT: Screen should be omitted from Component. It should be in Method.; Previous Releases: The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
184 |
| 8900-3 |
Arterial pulse intensity |
Force |
Carotid artery.left |
Pt |
Ord |
Palpation |
|
ACTIVE |
Pulse intensity Carotid artery - left by palpation |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HRTRATE.MOLEC |
|
8900-3 |
|
Palpation |
|
|
|
|
|
|
0 |
Pulse intensity Carot a-L Palpation |
|
|
|
|
|
Art; Cardio; Cardiology; Carot a; Carot a-L; Heart Disease; Heart Rate; HEART RATE.MOLEC; L; LT; Mechanical force; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen |
2.38 |
1.0h(3) |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 89000-4 |
Ethyl glucuronide |
MCnt |
Hair |
Pt |
Qn |
Confirm |
|
ACTIVE |
Ethyl glucuronide [Mass/mass] in Hair by Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
pg/mg |
|
|
|
|
|
|
DRUG/TOX |
|
89000-4 |
|
Confirm |
|
|
Both |
|
|
|
0 |
Ethyl glucuronide Hair Cfm-mCnt |
|
|
|
|
|
Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; EtG; Ethanol metabolite; GCMS; Gluc; Glucouronide; Har; LC/MS/MS; Mass content; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.65 |
2.64 |
|
|
|
|
|
|
|
pg/mg |
|
|
|
0 |
| 89001-2 |
Cancer-associated gene Ab |
ACnc |
Ser/Plas |
Pt |
Qn |
IA |
|
ACTIVE |
CAGE Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
arb U/mL |
|
|
|
|
|
|
SERO |
|
89001-2 |
|
IA |
|
|
Both |
|
|
|
0 |
CAGE Ab SerPl IA-aCnc |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Assoc; Autoantibodies; Autoantibody; CAGE; CAGE Ab; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; MEIA; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS |
2.73 |
2.64 |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
| 89002-0 |
GBU4-5 Ab |
ACnc |
Ser/Plas |
Pt |
Qn |
IA |
|
ACTIVE |
GBU4-5 Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
arb U/mL |
|
|
|
|
|
|
SERO |
|
89002-0 |
|
IA |
|
|
Both |
|
|
|
0 |
GBU4-5 Ab SerPl IA-aCnc |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; MEIA; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS |
2.73 |
2.64 |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
| 89003-8 |
HuD Ab |
ACnc |
Ser/Plas |
Pt |
Qn |
IA |
|
ACTIVE |
HuD Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
arb U/mL |
|
|
|
|
|
|
SERO |
|
89003-8 |
|
IA |
|
|
Both |
|
|
|
0 |
HuD Ab SerPl IA-aCnc |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; MEIA; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS |
2.73 |
2.64 |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
| 89004-6 |
Melanoma-associated antigen A4 Ab |
ACnc |
Ser/Plas |
Pt |
Qn |
IA |
|
ACTIVE |
MAGE A4 Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
arb U/mL |
|
|
|
|
|
|
SERO |
|
89004-6 |
|
IA |
|
|
Both |
|
|
|
0 |
MAGE A4 Ab SerPl IA-aCnc |
|
|
|
|
|
ABS; Aby; Ag; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Assoc; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; MAGE A4; MAGE A4 Ab; MEIA; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS |
2.73 |
2.64 |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
| 89005-3 |
NY-ESO-1 Ab |
ACnc |
Ser/Plas |
Pt |
Qn |
IA |
|
ACTIVE |
NY-ESO-1 Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
arb U/mL |
|
|
|
|
|
|
SERO |
|
89005-3 |
|
IA |
|
|
Both |
|
|
|
0 |
NY-ESO-1 Ab SerPl IA-aCnc |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; CTAG1; EIA; ELFA; ELISA; Enzyme immunoassay; i; IAA; MEIA; New York esophageal squamous cell carcinoma 1; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS |
2.73 |
2.64 |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
| 89006-1 |
p53 Ab |
ACnc |
Ser/Plas |
Pt |
Qn |
IA |
|
ACTIVE |
p53 Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
arb U/mL |
|
|
|
|
|
|
SERO |
|
89006-1 |
|
IA |
|
|
Both |
|
|
|
0 |
p53 Ab SerPl IA-aCnc |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; MEIA; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS |
2.73 |
2.64 |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
| 89007-9 |
SOX-2 Ab |
ACnc |
Ser/Plas |
Pt |
Qn |
IA |
|
ACTIVE |
SOX-2 Ab [Units/volume] in Serum or Plasma by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
arb U/mL |
|
|
|
|
|
|
SERO |
|
89007-9 |
|
IA |
|
|
Both |
|
|
|
0 |
SOX-2 Ab SerPl IA-aCnc |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; II; MEIA; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SRY (sex determinig region Y)-box 2; SUDS |
2.73 |
2.64 |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
| 89008-7 |
Station name |
ID |
EMS system |
Pt |
Nom |
|
|
ACTIVE |
Station name [Identifier] EMS system |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
TRAUMA |
|
89008-7 |
|
|
|
|
Observation |
|
|
|
0 |
Station name EMS Sys |
|
|
|
|
|
Emergency Medical Service(s); EMS; Ident; Identifier; NEMSIS; Nominal; Point in time; Random; TRAUMA |
2.7 |
2.64 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 89009-5 |
Encounter location |
Type |
^Patient |
Pt |
Nom |
|
|
ACTIVE |
Encounter location [Type] |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
TRAUMA |
|
89009-5 |
|
|
|
|
Observation |
|
|
|
0 |
Encounter location Type |
|
|
|
|
|
Nominal; Point in time; Random; TRAUMA; Typ |
2.7 |
2.64 |
|
|
|
|
|
|
|
|
|
|
Release 2.70: DefinitionDescription: Updated description for clarity.; |
0 |
| 8901-1 |
Arterial pulse intensity |
Force |
Carotid artery.right |
Pt |
Ord |
Palpation |
|
ACTIVE |
Pulse intensity Carotid artery - right by palpation |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HRTRATE.MOLEC |
|
8901-1 |
|
Palpation |
|
|
|
|
|
|
0 |
Pulse intensity Carot a-R Palpation |
|
|
|
|
|
Art; Cardio; Cardiology; Carot a; Carot a-R; Heart Disease; Heart Rate; HEART RATE.MOLEC; Mechanical force; Ordinal; Point in time; QL; Qual; Qualitative; R; Random; RT; Screen |
2.38 |
1.0h(3) |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 89010-3 |
EMS physician name |
Pn |
Provider |
Pt |
Nom |
|
|
ACTIVE |
EMS physician name |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
TRAUMA |
|
89010-3 |
|
|
|
|
Observation |
|
|
|
0 |
EMS MD name |
|
|
|
|
|
Emergency Medical Service(s); EMS MD name; Nominal; Person name; Point in time; Random; TRAUMA |
2.7 |
2.64 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 89011-1 |
EMS assistant name |
Pn |
Provider |
Pt |
Nom |
|
|
ACTIVE |
EMS assistant name |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
TRAUMA |
|
89011-1 |
|
|
|
|
Observation |
|
|
|
0 |
EMS assistant name |
|
|
|
|
|
Emergency Medical Service(s); Nominal; Person name; Point in time; Random; TRAUMA |
2.7 |
2.64 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 89012-9 |
EMS assistant qualification |
Type |
Provider |
Pt |
Nom |
|
|
ACTIVE |
EMS assistant qualification |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
TRAUMA |
|
89012-9 |
|
|
|
|
Observation |
|
|
|
0 |
EMS assistant qual |
|
|
|
|
|
Emergency Medical Service(s); Nominal; Point in time; Random; TRAUMA; Typ |
2.7 |
2.64 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 89013-7 |
Certified first responder was on site when EMS unit arrived |
Find |
^Patient |
Pt |
Ord |
|
|
ACTIVE |
Certified first responder was on site when EMS unit arrived |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
TRAUMA |
|
89013-7 |
|
|
|
|
Observation |
|
|
|
0 |
Cert first responder on site pre EMS |
|
|
|
|
|
Cert first responder on site pre EMS; Emergency Medical Service(s); Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; TRAUMA |
2.7 |
2.64 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 89014-5 |
Oxygen was used for preoxygenation |
Find |
^Patient |
Pt |
Nom |
|
|
ACTIVE |
Oxygen was used for preoxygenation |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PULM |
|
89014-5 |
|
|
|
|
Observation |
|
|
|
0 |
Oxygen for preoxygenation |
|
|
|
|
|
Finding; Findings; Lung; Nominal; O2; Oxygen for preoxygenation; Point in time; PULMONARY; Pulmonology; Random; Respiratory; tO2 |
2.7 |
2.64 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 89015-2 |
Pure tone threshold audiometry panel |
- |
Ear |
Pt |
- |
|
|
ACTIVE |
Pure tone threshold audiometry panel |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.CLIN |
|
89015-2 |
|
|
|
|
Order |
|
|
|
0 |
Pure tone thresh Pnl |
|
|
|
|
|
CLIN; Hearing; Otologic; Pan; PANEL.CLINICAL; Panl; Pnl; Point in time; Pure tone thresh Pnl; Random |
2.72 |
2.64 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 89016-0 |
Hearing threshold^1000 Hz |
RelSoundInt |
Ear.left |
Pt |
Qn |
|
|
ACTIVE |
Hearing threshold Ear - left --1000 Hz |
|
ADD |
DefinitionDescription |
|
|
dB HL |
|
|
|
|
|
|
AUDIO |
|
89016-0 |
|
|
|
|
Observation |
|
|
|
0 |
Hearing threshold 1000 Hz Ear-L |
|
|
|
|
|
AUDIO; Audiology; Ear-L; Hearing; L; LT; Otologic; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.64 |
2.64 |
|
|
|
|
|
|
|
dB |
|
|
|
0 |
| 89017-8 |
Hearing threshold^1000 Hz |
RelSoundInt |
Ear.right |
Pt |
Qn |
|
|
ACTIVE |
Hearing threshold Ear - right --1000 Hz |
|
ADD |
DefinitionDescription |
|
|
dB HL |
|
|
|
|
|
|
AUDIO |
|
89017-8 |
|
|
|
|
Observation |
|
|
|
0 |
Hearing threshold 1000 Hz Ear-R |
|
|
|
|
|
AUDIO; Audiology; Ear-R; Hearing; Otologic; Point in time; QNT; Quan; Quant; Quantitative; R; Random; RT |
2.64 |
2.64 |
|
|
|
|
|
|
|
dB |
|
|
|
0 |
| 89018-6 |
Hearing threshold^2000 Hz |
RelSoundInt |
Ear.left |
Pt |
Qn |
|
|
ACTIVE |
Hearing threshold Ear - left --2000 Hz |
|
ADD |
DefinitionDescription |
|
|
dB HL |
|
|
|
|
|
|
AUDIO |
|
89018-6 |
|
|
|
|
Observation |
|
|
|
0 |
Hearing threshold 2000 Hz Ear-L |
|
|
|
|
|
AUDIO; Audiology; Ear-L; Hearing; L; LT; Otologic; Point in time; QNT; Quan; Quant; Quantitative; Random |
2.64 |
2.64 |
|
|
|
|
|
|
|
dB |
|
|
|
0 |
| 89019-4 |
Hearing threshold^2000 Hz |
RelSoundInt |
Ear.right |
Pt |
Qn |
|
|
ACTIVE |
Hearing threshold Ear - right --2000 Hz |
|
ADD |
DefinitionDescription |
|
|
dB HL |
|
|
|
|
|
|
AUDIO |
|
89019-4 |
|
|
|
|
Observation |
|
|
|
0 |
Hearing threshold 2000 Hz Ear-R |
|
|
|
|
|
AUDIO; Audiology; Ear-R; Hearing; Otologic; Point in time; QNT; Quan; Quant; Quantitative; R; Random; RT |
2.64 |
2.64 |
|
|
|
|
|
|
|
dB |
|
|
|
0 |
